322 related articles for article (PubMed ID: 10465311)
1. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.
Hofbauer LC; Khosla S; Dunstan CR; Lacey DL; Spelsberg TC; Riggs BL
Endocrinology; 1999 Sep; 140(9):4367-70. PubMed ID: 10465311
[TBL] [Abstract][Full Text] [Related]
2. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
[TBL] [Abstract][Full Text] [Related]
3. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts.
Viereck V; Gründker C; Blaschke S; Siggelkow H; Emons G; Hofbauer LC
J Cell Biochem; 2002; 84(4):725-35. PubMed ID: 11835398
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts.
Viereck V; Gründker C; Blaschke S; Niederkleine B; Siggelkow H; Frosch KH; Raddatz D; Emons G; Hofbauer LC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4206-13. PubMed ID: 12970288
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.
Hofbauer LC; Gori F; Riggs BL; Lacey DL; Dunstan CR; Spelsberg TC; Khosla S
Endocrinology; 1999 Oct; 140(10):4382-9. PubMed ID: 10499489
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines.
Hofbauer LC; Dunstan CR; Spelsberg TC; Riggs BL; Khosla S
Biochem Biophys Res Commun; 1998 Sep; 250(3):776-81. PubMed ID: 9784422
[TBL] [Abstract][Full Text] [Related]
7. 17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha.
Saika M; Inoue D; Kido S; Matsumoto T
Endocrinology; 2001 Jun; 142(6):2205-12. PubMed ID: 11356664
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC
J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630
[TBL] [Abstract][Full Text] [Related]
10. The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts.
Bord S; Ireland DC; Beavan SR; Compston JE
Bone; 2003 Feb; 32(2):136-41. PubMed ID: 12633785
[TBL] [Abstract][Full Text] [Related]
11. A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets.
De Wilde A; Lieberherr M; Colin C; Pointillart A
J Cell Physiol; 2004 Aug; 200(2):253-62. PubMed ID: 15174095
[TBL] [Abstract][Full Text] [Related]
12. Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells.
Chen WF; Wong MS
Br J Nutr; 2006 Jun; 95(6):1039-47. PubMed ID: 16768824
[TBL] [Abstract][Full Text] [Related]
13. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
Humphrey EL; Williams JH; Davie MW; Marshall MJ
Bone; 2006 May; 38(5):652-61. PubMed ID: 16298558
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
Lee SK; Lorenzo JA
Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
[TBL] [Abstract][Full Text] [Related]
15. Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells.
Hofbauer LC; Hicok KC; Chen D; Khosla S
Eur J Endocrinol; 2002 Aug; 147(2):269-73. PubMed ID: 12153751
[TBL] [Abstract][Full Text] [Related]
16. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells.
Hofbauer LC; Shui C; Riggs BL; Dunstan CR; Spelsberg TC; O'Brien T; Khosla S
Biochem Biophys Res Commun; 2001 Jan; 280(1):334-9. PubMed ID: 11162519
[TBL] [Abstract][Full Text] [Related]
17. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.
Wang QP; Yang L; Li XP; Xie H; Liao EY; Wang M; Luo XH
Bone; 2012 Sep; 51(3):515-23. PubMed ID: 22634178
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of 17beta-E2 and progesterone on the expression of osteoprotegerin in normal human osteoblast-like cells.
Liao EY; Luo XH; Su X
J Endocrinol Invest; 2002 Oct; 25(9):785-90. PubMed ID: 12398237
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts.
Rickard DJ; Waters KM; Ruesink TJ; Khosla S; Katzenellenbogen JA; Katzenellenbogen BS; Riggs BL; Spelsberg TC
J Bone Miner Res; 2002 Apr; 17(4):580-92. PubMed ID: 11918216
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats.
Wang FS; Wang CJ; Chen YJ; Huang YT; Huang HC; Chang PR; Sun YC; Yang KD
Endocrinology; 2004 May; 145(5):2148-56. PubMed ID: 14962990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
